Physician profile
James Peter Lacey
NPI 1164457081
$3,354.12
in general payments reported to CMS, 2019-2025
12 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $70.88 · 2021: $702 · 2022: $737 · 2023: $164 · 2024: $1,397 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397 · Travel and Lodging: $414 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.15 |
| Travel and Lodging | $413.70 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,007.42 | 2021-2025 | Inspire |
| Medtronic, INC. | $74.49 | 2021 | |
| Stryker Corporation | $56.33 | 2022 | |
| Genzyme Corporation | $51.13 | 2020-2022 | |
| Acclarent, INC | $38.08 | 2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Checkpoint Surgical, INC | $19.80 | 2022 | |
| Phadia US INC. | $16.63 | 2022 | |
| Medtronic USA, INC. | $16.35 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.93 | 2022 | |
| Kaleo, INC. | $12.77 | 2021 | |
| Hologic Sales and Service, LLC | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lacey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.